Compare CLDX & CHRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CLDX | CHRN |
|---|---|---|
| Founded | N/A | 2026 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 2.9B |
| IPO Year | 1995 | 2012 |
| Metric | CLDX | CHRN |
|---|---|---|
| Price | $28.36 | $10.37 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 15 | 2 |
| Target Price | ★ $63.07 | $28.50 |
| AVG Volume (30 Days) | ★ 1.1M | 144.2K |
| Earning Date | 11-17-2026 | 11-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 92.67 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $12,743,000.00 | N/A |
| Revenue This Year | $19.74 | $84.77 |
| Revenue Next Year | $373.52 | $603.10 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 87.78 | N/A |
| 52 Week Low | $22.10 | $11.41 |
| 52 Week High | $45.14 | $30.00 |
| Indicator | CLDX | CHRN |
|---|---|---|
| Relative Strength Index (RSI) | 45.96 | 33.86 |
| Support Level | $28.34 | N/A |
| Resistance Level | $31.47 | $22.29 |
| Average True Range (ATR) | 1.35 | 1.59 |
| MACD | 0.35 | -0.24 |
| Stochastic Oscillator | 71.35 | 9.73 |
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
ChronoScale Holdings Corp is providing cloud services to customers at third-party colocation centers located in Colorado, Minnesota and Utah, such as artificial intelligence and machine learning developers, seeking to develop their products. It design, develop, and market exoskeleton and complementary products that augment human strength, endurance, and mobility. Its Cloud Business provides graphics processing unit (GPU) computing solutions that enable customers to execute critical workloads related to artificial intelligence (AI), machine learning (ML), rendering, and other High Performance Computing (HPC) tasks at scale in a capacity-constrained market. It has one operating segment Cloud Business.